Sai Life Sciences Ltd (SAILIFE) Stock Price & News

SAILIFE:NSE

Sai Life Sciences Ltd

₹1,560.50

+4.33%

(+64.80) 1D

Oct 30, 3:30:02 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Next call in 4 days

Fri, Nov 6, 12:30 AM

Fiscal period

Q2 2027

- / ₹4.10

Revenue / Est. (INR)

- / 5.95B

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5.37B	5.56B	6.02B	5.54B
Cost of goods sold	1.40B	1.28B	2.27B	1.45B
Cost of revenue	1.40B	1.28B	2.27B	1.45B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.63B	1.73B	1.96B	1.80B
Operating expense	2.91B	2.85B	2.43B	3.07B
Total operating expenses	4.31B	4.13B	4.70B	4.52B
Operating income	1.06B	1.44B	1.32B	1.02B
Other non operating income	153.25M	83.80M	-333.80M	35.43M
EBT including unusual items	1.12B	1.34B	1.39B	979.74M
EBT excluding unusual items	1.12B	1.42B	1.39B	979.74M
Income tax expense	282.07M	337.91M	349.91M	246.89M
Effective tax rate	25.17%	25.19%	25.13%	25.20%
Other operating expenses	887.29M	676.72M	14.63M	814.72M
Net income	838.44M	1.00B	1.04B	732.85M
Net profit margin	15.60%	18.04%	17.31%	13.22%
Earnings per share	3.93	5.00	4.86	3.42
Interest and investment income	-	-	186.18M	-
Interest expense	-93.51M	-96.99M	-78.25M	-76.36M
Net interest expenses	-93.51M	-96.99M	107.93M	-76.36M
Depreciation and amortization charges	397.48M	440.75M	453.08M	459.37M
EBITDA	1.45B	1.66B	1.60B	1.44B
Gain or loss from assets sale	-	-	-	-

Finance